Authors:
TORRES CG
LUNDBY B
STERUD AT
MCGILL S
GORDON PB
BJERKNES HS
Citation: Cg. Torres et al., MNDPDP FOR MR-IMAGING OF THE LIVER - RESULTS FROM THE EUROPEAN PHASE-III STUDIES, Acta radiologica, 38(4), 1997, pp. 631-637
Authors:
RUMMENY EJ
TORRES CG
KURDZIEL JC
NILSEN G
OPDEBEECK B
LUNDBY B
Citation: Ej. Rummeny et al., MNDPDP FOR MR-IMAGING OF THE LIVER - RESULTS OF AN INDEPENDENT IMAGE EVALUATION OF THE EUROPEAN PHASE-III STUDIES, Acta radiologica, 38(4), 1997, pp. 638-642
Authors:
JACOBSEN TF
LANIADO M
VANBEERS BE
DUPAS B
BOUDGHENE FP
RUMMENY E
FALKE THM
RINCK PA
MACVICAR D
LUNDBY B
Citation: Tf. Jacobsen et al., ORAL MAGNETIC PARTICLES (FERRISTENE) AS A CONTRAST-MEDIUM IN ABDOMINAL MAGNETIC-RESONANCE-IMAGING, Academic radiology, 3(7), 1996, pp. 571-580
Authors:
HOGSTROM B
KRISTOFFERSEN DT
LUNDBY B
SVALAND MG
Citation: B. Hogstrom et al., SAFETY OF GADODIAMIDE INJECTION IN 2 DIFFERENT AGE-GROUPS, Journal of magnetic resonance imaging, 6(1), 1996, pp. 255-257
Citation: B. Lundby et al., MRI IN CHILDREN GIVEN GADODIAMIDE INJECTION - SAFETY AND EFFICACY IN CNS AND BODY INDICATIONS, European journal of radiology, 23(3), 1996, pp. 190-196
Authors:
VANBEERS BE
GRANDIN C
DEGREEF D
LUNDBY B
PRINGOT J
Citation: Be. Vanbeers et al., FERRISTENE AS INTESTINAL MR CONTRAST AGENT - DISTRIBUTION AND SAFETY OF A FAST INGESTION PROCEDURE WITH ORAL METOCLOPRAMIDE, Acta radiologica, 37(5), 1996, pp. 676-679
Authors:
RUMMENY EJ
KURDZIEL JC
NILSEN G
DEBEECK O
TORRES C
LUNDBY B
Citation: Ej. Rummeny et al., MN-DPDP-ENHANCED MR-IMAGING OF THE LIVER - FINAL RESULTS OF THE EUROPEAN PHASE-III STUDIES IN 592 PATIENTS, Radiology, 201, 1996, pp. 488-488
Authors:
ASLANIAN V
LEMAIGNEN H
BUNOUF P
SVALAND MG
BORSETH A
LUNDBY B
Citation: V. Aslanian et al., EVALUATION OF THE CLINICAL SAFETY OF GADODIAMIDE INJECTION, A NEW NONIONIC MRI CONTRAST-MEDIUM FOR THE CENTRAL-NERVOUS-SYSTEM - A EUROPEAN PERSPECTIVE, Neuroradiology, 38(6), 1996, pp. 537-541
Authors:
BERG KJ
LUNDBY B
REINTON V
NORDAL KP
ROOTWELT K
SMITH HJ
Citation: Kj. Berg et al., GADODIAMIDE IN RENAL-TRANSPLANT PATIENTS - EFFECTS ON RENAL-FUNCTION AND USEFULNESS AS A GLOMERULAR-FILTRATION RATE MARKER, Nephron, 72(2), 1996, pp. 212-217
Authors:
ASLANIAN V
LEMAIGNEN H
BUNOUF P
SCHIRATTI M
LAMBRECHTS M
LUNDBY B
BORSETH A
SVALAND M
Citation: V. Aslanian et al., EVALUATION OF THE CLINICAL SAFETY OF GADO DIAMIDE INJECTION (OMNISCAN(R)), A NEW NONIONIC MR CONTRAST AGENT FOR THE CENTRAL-NERVOUS-SYSTEM, Journal de radiologie, 76(7), 1995, pp. 431-434
Citation: Pb. Gordon et al., SAFETY, TOLERABILITY, AND MR-IMAGING EFFICACY OF GADODIAMIDE INJECTION IN PEDIATRIC-PATIENTS EXAMINED FOR CENTRAL-NERVOUS-SYSTEM AND NONCENTRAL NERVOUS-SYSTEM INDICATIONS, Radiology, 197, 1995, pp. 432-432
Citation: Mg. Svaland et al., COMPARISON OF THE SAFETY OF THE STANDARD-DOSE AND A HIGHER DOSE OF GADODIAMIDE INJECTION FOR MR-IMAGING OF THE CENTRAL-NERVOUS-SYSTEM, Journal of magnetic resonance imaging, 4(3), 1994, pp. 419-423
Authors:
ANDREW E
SVALAND M
LUNDBY B
HUGO F
LAFRANCE N
Citation: E. Andrew et al., CLINICAL-EXPERIENCE WITH GADODIAMIDE INJECTION IN MAGNETIC-RESONANCE-IMAGING OF THE CENTRAL-NERVOUS-SYSTEM, Investigative radiology, 29, 1994, pp. 190000186-190000188
Citation: B. Lundby et al., A DOUBLE-BLIND-STUDY TO EVALUATE THE TOLERABILITY OF GADODIAMIDE INJECTION AND ITS EFFECT ON RENAL-FUNCTION IN PATIENTS UNDERGOING CEREBRALMAGNETIC-RESONANCE-IMAGING, British journal of radiology, 66(790), 1993, pp. 871-876